199 related articles for article (PubMed ID: 10197087)
1. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
[TBL] [Abstract][Full Text] [Related]
2. Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
Isidori AM; Kaltsas G; Frajese V; Kola B; Whitelocke RA; Plowman PN; Britton KE; Monson JP; Grossman AB; Besser GM
J Clin Endocrinol Metab; 2002 Apr; 87(4):1627-33. PubMed ID: 11932293
[TBL] [Abstract][Full Text] [Related]
3. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.
Zuetenhorst JM; Hoefnageli CA; Boot H; Valdés Olmos RA; Taal BG
Nucl Med Commun; 2002 Aug; 23(8):735-41. PubMed ID: 12124478
[TBL] [Abstract][Full Text] [Related]
5. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
[TBL] [Abstract][Full Text] [Related]
6. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
7. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
[TBL] [Abstract][Full Text] [Related]
8. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
[TBL] [Abstract][Full Text] [Related]
9. Octreotide scanning for carcinoid tumours.
Critchley M
Postgrad Med J; 1997 Jul; 73(861):399-402. PubMed ID: 9338023
[TBL] [Abstract][Full Text] [Related]
10. Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
Dworakowska D; Gueorguiev M; Laji K; Grossman AB
Endokrynol Pol; 2008; 59(4):342-7. PubMed ID: 18777505
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
Virgolini I; Angelberger P; Li S; Yang Q; Kurtaran A; Raderer M; Neuhold N; Kaserer K; Leimer M; Peck-Radosavljevic M; Scheithauer W; Niederle B; Eichler HG; Valent P
Eur J Nucl Med; 1996 Oct; 23(10):1388-99. PubMed ID: 8781146
[TBL] [Abstract][Full Text] [Related]
12. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
[TBL] [Abstract][Full Text] [Related]
15. 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET.
Yüksel M; Eziddin S; Ladwein E; Haas S; Biersack HJ
Ann Nucl Med; 2005 Oct; 19(7):611-5. PubMed ID: 16363628
[TBL] [Abstract][Full Text] [Related]
16. Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy.
Musi M; Carbone RG; Bertocchi C; Cantalupi DP; Michetti G; Pugliese C; Virotta G
Lung Cancer; 1998 Nov; 22(2):97-102. PubMed ID: 10022217
[TBL] [Abstract][Full Text] [Related]
17. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
[TBL] [Abstract][Full Text] [Related]
18. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
19. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
Dresel S; Tatsch K; Zachoval R; Hahn K
Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
[TBL] [Abstract][Full Text] [Related]
20. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.
Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG
J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
